nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—ABCB1—Sorafenib—thyroid cancer	0.0576	0.281	CbGbCtD
Prednisolone—CYP3A4—Vandetanib—thyroid cancer	0.0573	0.279	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—thyroid cancer	0.035	0.17	CbGbCtD
Prednisolone—CYP3A4—Sorafenib—thyroid cancer	0.0345	0.168	CbGbCtD
Prednisolone—Impaired healing—Vandetanib—thyroid cancer	0.026	0.0427	CcSEcCtD
Prednisolone—Thromboembolism—Sorafenib—thyroid cancer	0.0239	0.0392	CcSEcCtD
Prednisolone—CYP3A4—Doxorubicin—thyroid cancer	0.0209	0.102	CbGbCtD
Prednisolone—Embolism venous—Sorafenib—thyroid cancer	0.015	0.0247	CcSEcCtD
Prednisolone—Glaucoma—Vandetanib—thyroid cancer	0.0149	0.0245	CcSEcCtD
Prednisolone—Acne—Vandetanib—thyroid cancer	0.0134	0.022	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0127	0.0685	CbGpPWpGaD
Prednisolone—NR3C2—Preimplantation Embryo—NKX2-1—thyroid cancer	0.012	0.0648	CbGpPWpGaD
Prednisolone—Embolism—Sorafenib—thyroid cancer	0.0118	0.0194	CcSEcCtD
Prednisolone—NR3C2—Preimplantation Embryo—TCF7L1—thyroid cancer	0.0106	0.0571	CbGpPWpGaD
Prednisolone—Thromboembolism—Epirubicin—thyroid cancer	0.00882	0.0145	CcSEcCtD
Prednisolone—Dermatitis bullous—Vandetanib—thyroid cancer	0.00855	0.014	CcSEcCtD
Prednisolone—Thromboembolism—Doxorubicin—thyroid cancer	0.00816	0.0134	CcSEcCtD
Prednisolone—Cardiac arrest—Vandetanib—thyroid cancer	0.00777	0.0128	CcSEcCtD
Prednisolone—Cardiomegaly—Epirubicin—thyroid cancer	0.00769	0.0126	CcSEcCtD
Prednisolone—Dry skin—Vandetanib—thyroid cancer	0.00749	0.0123	CcSEcCtD
Prednisolone—Neuropathy—Sorafenib—thyroid cancer	0.00713	0.0117	CcSEcCtD
Prednisolone—Cardiomegaly—Doxorubicin—thyroid cancer	0.00712	0.0117	CcSEcCtD
Prednisolone—Pancreatitis—Vandetanib—thyroid cancer	0.00692	0.0114	CcSEcCtD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00675	0.0363	CbGpPWpGaD
Prednisolone—Leukoderma—Epirubicin—thyroid cancer	0.0066	0.0108	CcSEcCtD
Prednisolone—Conjunctivitis—Vandetanib—thyroid cancer	0.00612	0.0101	CcSEcCtD
Prednisolone—Leukoderma—Doxorubicin—thyroid cancer	0.00611	0.01	CcSEcCtD
Prednisolone—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00608	0.00998	CcSEcCtD
Prednisolone—SLCO1A2—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00604	0.0325	CbGpPWpGaD
Prednisolone—Bradycardia—Vandetanib—thyroid cancer	0.00575	0.00945	CcSEcCtD
Prednisolone—Haemoglobin—Vandetanib—thyroid cancer	0.00568	0.00933	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.00568	0.0305	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00565	0.0304	CbGpPWpGaD
Prednisolone—Haemorrhage—Vandetanib—thyroid cancer	0.00565	0.00928	CcSEcCtD
Prednisolone—Embolism venous—Epirubicin—thyroid cancer	0.00556	0.00913	CcSEcCtD
Prednisolone—Visual impairment—Vandetanib—thyroid cancer	0.00545	0.00895	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00541	0.0291	CbGpPWpGaD
Prednisolone—Hypernatraemia—Epirubicin—thyroid cancer	0.00534	0.00876	CcSEcCtD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00529	0.0285	CbGpPWpGaD
Prednisolone—Mood swings—Sorafenib—thyroid cancer	0.00522	0.00857	CcSEcCtD
Prednisolone—Embolism venous—Doxorubicin—thyroid cancer	0.00514	0.00845	CcSEcCtD
Prednisolone—Dry skin—Sorafenib—thyroid cancer	0.00505	0.0083	CcSEcCtD
Prednisolone—Arrhythmia—Vandetanib—thyroid cancer	0.00505	0.00829	CcSEcCtD
Prednisolone—Hypernatraemia—Doxorubicin—thyroid cancer	0.00494	0.00811	CcSEcCtD
Prednisolone—Pancreatitis—Sorafenib—thyroid cancer	0.00467	0.00767	CcSEcCtD
Prednisolone—Vision blurred—Vandetanib—thyroid cancer	0.00464	0.00762	CcSEcCtD
Prednisolone—Optic neuritis—Epirubicin—thyroid cancer	0.00456	0.00749	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00448	0.0241	CbGpPWpGaD
Prednisolone—Embolism—Epirubicin—thyroid cancer	0.00437	0.00718	CcSEcCtD
Prednisolone—Keratitis—Epirubicin—thyroid cancer	0.00433	0.0071	CcSEcCtD
Prednisolone—Loss of consciousness—Vandetanib—thyroid cancer	0.00432	0.0071	CcSEcCtD
Prednisolone—Convulsion—Vandetanib—thyroid cancer	0.00426	0.007	CcSEcCtD
Prednisolone—Hypertension—Vandetanib—thyroid cancer	0.00425	0.00698	CcSEcCtD
Prednisolone—Optic neuritis—Doxorubicin—thyroid cancer	0.00422	0.00693	CcSEcCtD
Prednisolone—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00419	0.00688	CcSEcCtD
Prednisolone—Myocardial infarction—Sorafenib—thyroid cancer	0.00416	0.00684	CcSEcCtD
Prednisolone—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00416	0.00684	CcSEcCtD
Prednisolone—Embolism—Doxorubicin—thyroid cancer	0.00404	0.00664	CcSEcCtD
Prednisolone—Oedema—Vandetanib—thyroid cancer	0.00402	0.00659	CcSEcCtD
Prednisolone—Keratitis—Doxorubicin—thyroid cancer	0.004	0.00657	CcSEcCtD
Prednisolone—Hepatomegaly—Epirubicin—thyroid cancer	0.00396	0.00651	CcSEcCtD
Prednisolone—Blister—Epirubicin—thyroid cancer	0.00389	0.00639	CcSEcCtD
Prednisolone—Haemoglobin—Sorafenib—thyroid cancer	0.00383	0.00629	CcSEcCtD
Prednisolone—Haemorrhage—Sorafenib—thyroid cancer	0.00381	0.00626	CcSEcCtD
Prednisolone—Dermatitis atopic—Epirubicin—thyroid cancer	0.00379	0.00623	CcSEcCtD
Prednisolone—Neuritis—Epirubicin—thyroid cancer	0.00376	0.00617	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.00373	0.0201	CbGpPWpGaD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.00373	0.0201	CbGpPWpGaD
Prednisolone—Hepatomegaly—Doxorubicin—thyroid cancer	0.00367	0.00602	CcSEcCtD
Prednisolone—Insomnia—Vandetanib—thyroid cancer	0.00363	0.00596	CcSEcCtD
Prednisolone—Paraesthesia—Vandetanib—thyroid cancer	0.00361	0.00592	CcSEcCtD
Prednisolone—Blister—Doxorubicin—thyroid cancer	0.0036	0.00592	CcSEcCtD
Prednisolone—Abscess—Epirubicin—thyroid cancer	0.00355	0.00582	CcSEcCtD
Prednisolone—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00351	0.00576	CcSEcCtD
Prednisolone—Neuritis—Doxorubicin—thyroid cancer	0.00348	0.00571	CcSEcCtD
Prednisolone—Stinging—Epirubicin—thyroid cancer	0.00346	0.00569	CcSEcCtD
Prednisolone—Pain—Vandetanib—thyroid cancer	0.00343	0.00564	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00342	0.0184	CbGpPWpGaD
Prednisolone—Petechiae—Epirubicin—thyroid cancer	0.00341	0.0056	CcSEcCtD
Prednisolone—Arrhythmia—Sorafenib—thyroid cancer	0.00341	0.00559	CcSEcCtD
Prednisolone—Erythema—Sorafenib—thyroid cancer	0.00332	0.00545	CcSEcCtD
Prednisolone—Abscess—Doxorubicin—thyroid cancer	0.00328	0.00539	CcSEcCtD
Prednisolone—Stinging—Doxorubicin—thyroid cancer	0.0032	0.00526	CcSEcCtD
Prednisolone—SLCO1A2—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.00316	0.017	CbGpPWpGaD
Prednisolone—Petechiae—Doxorubicin—thyroid cancer	0.00316	0.00518	CcSEcCtD
Prednisolone—Viral infection—Epirubicin—thyroid cancer	0.00311	0.0051	CcSEcCtD
Prednisolone—Arthropathy—Epirubicin—thyroid cancer	0.00309	0.00507	CcSEcCtD
Prednisolone—Herpes simplex—Epirubicin—thyroid cancer	0.00304	0.005	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00304	0.0164	CbGpPWpGaD
Prednisolone—Angioedema—Sorafenib—thyroid cancer	0.00303	0.00498	CcSEcCtD
Prednisolone—Syncope—Sorafenib—thyroid cancer	0.00298	0.00489	CcSEcCtD
Prednisolone—Loss of consciousness—Sorafenib—thyroid cancer	0.00292	0.00479	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—thyroid cancer	0.00287	0.00472	CcSEcCtD
Prednisolone—Hypertension—Sorafenib—thyroid cancer	0.00287	0.00471	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—thyroid cancer	0.00285	0.00469	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—thyroid cancer	0.00282	0.00463	CcSEcCtD
Prednisolone—Hiccups—Epirubicin—thyroid cancer	0.00281	0.00461	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00271	0.0146	CbGpPWpGaD
Prednisolone—Anaphylactic shock—Sorafenib—thyroid cancer	0.00271	0.00445	CcSEcCtD
Prednisolone—Shock—Sorafenib—thyroid cancer	0.00266	0.00438	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—thyroid cancer	0.00266	0.00437	CcSEcCtD
Prednisolone—Dizziness—Vandetanib—thyroid cancer	0.00266	0.00436	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—thyroid cancer	0.00263	0.00433	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—thyroid cancer	0.0026	0.00426	CcSEcCtD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.00258	0.0139	CbGpPWpGaD
Prednisolone—Ecchymosis—Epirubicin—thyroid cancer	0.00254	0.00417	CcSEcCtD
Prednisolone—Rash—Vandetanib—thyroid cancer	0.00253	0.00416	CcSEcCtD
Prednisolone—Dermatitis—Vandetanib—thyroid cancer	0.00253	0.00415	CcSEcCtD
Prednisolone—Headache—Vandetanib—thyroid cancer	0.00252	0.00413	CcSEcCtD
Prednisolone—CYP2A6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.0025	0.0134	CbGpPWpGaD
Prednisolone—Pulmonary oedema—Epirubicin—thyroid cancer	0.0025	0.0041	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—thyroid cancer	0.00246	0.00405	CcSEcCtD
Prednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.00246	0.0132	CbGpPWpGaD
Prednisolone—Neuropathy—Doxorubicin—thyroid cancer	0.00244	0.004	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.00241	0.013	CbGpPWpGaD
Prednisolone—Nausea—Vandetanib—thyroid cancer	0.00238	0.00392	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00236	0.0127	CbGpPWpGaD
Prednisolone—Thrombophlebitis—Epirubicin—thyroid cancer	0.00235	0.00386	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—thyroid cancer	0.00235	0.00385	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—thyroid cancer	0.00234	0.00385	CcSEcCtD
Prednisolone—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00232	0.0125	CbGpPWpGaD
Prednisolone—Pain—Sorafenib—thyroid cancer	0.00232	0.0038	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00231	0.0038	CcSEcCtD
Prednisolone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00225	0.00369	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—THRB—thyroid cancer	0.0022	0.0118	CbGpPWpGaD
Prednisolone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00218	0.00358	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—thyroid cancer	0.00217	0.00356	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00217	0.00356	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—thyroid cancer	0.00216	0.0116	CbGpPWpGaD
Prednisolone—Urticaria—Sorafenib—thyroid cancer	0.00215	0.00353	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—thyroid cancer	0.00213	0.0035	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.0021	0.00346	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00208	0.00341	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—thyroid cancer	0.00204	0.00334	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—thyroid cancer	0.00201	0.00329	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—thyroid cancer	0.002	0.00329	CcSEcCtD
Prednisolone—Hypersensitivity—Sorafenib—thyroid cancer	0.002	0.00328	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00197	0.0106	CbGpPWpGaD
Prednisolone—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00197	0.00324	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00195	0.0032	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—thyroid cancer	0.00194	0.00318	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—thyroid cancer	0.00193	0.00317	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00191	0.0102	CbGpPWpGaD
Prednisolone—Osteoarthritis—Doxorubicin—thyroid cancer	0.00188	0.0031	CcSEcCtD
Prednisolone—Dry skin—Epirubicin—thyroid cancer	0.00187	0.00307	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—thyroid cancer	0.00185	0.00305	CcSEcCtD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00185	0.00994	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00183	0.00986	CbGpPWpGaD
Prednisolone—Muscular weakness—Epirubicin—thyroid cancer	0.0018	0.00295	CcSEcCtD
Prednisolone—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.00179	0.00965	CbGpPWpGaD
Prednisolone—Cardiac arrest—Doxorubicin—thyroid cancer	0.00179	0.00294	CcSEcCtD
Prednisolone—Dizziness—Sorafenib—thyroid cancer	0.00179	0.00294	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—thyroid cancer	0.00179	0.00293	CcSEcCtD
Prednisolone—Abdominal distension—Epirubicin—thyroid cancer	0.00177	0.00291	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—thyroid cancer	0.00173	0.00284	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—thyroid cancer	0.00173	0.00283	CcSEcCtD
Prednisolone—Rash—Sorafenib—thyroid cancer	0.00171	0.0028	CcSEcCtD
Prednisolone—Dermatitis—Sorafenib—thyroid cancer	0.00171	0.0028	CcSEcCtD
Prednisolone—Headache—Sorafenib—thyroid cancer	0.0017	0.00279	CcSEcCtD
Prednisolone—Muscular weakness—Doxorubicin—thyroid cancer	0.00166	0.00273	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—thyroid cancer	0.00164	0.00269	CcSEcCtD
Prednisolone—Nausea—Sorafenib—thyroid cancer	0.00161	0.00264	CcSEcCtD
Prednisolone—Weight increased—Epirubicin—thyroid cancer	0.0016	0.00263	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—thyroid cancer	0.0016	0.00262	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00159	0.00857	CbGpPWpGaD
Prednisolone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00154	0.00253	CcSEcCtD
Prednisolone—Conjunctivitis—Epirubicin—thyroid cancer	0.00153	0.00251	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.00152	0.00819	CbGpPWpGaD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00151	0.00812	CbGpPWpGaD
Prednisolone—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00149	0.00799	CbGpPWpGaD
Prednisolone—Weight increased—Doxorubicin—thyroid cancer	0.00148	0.00243	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—TRIM33—thyroid cancer	0.00147	0.00788	CbGpPWpGaD
Prednisolone—Bradycardia—Epirubicin—thyroid cancer	0.00143	0.00236	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00142	0.00234	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—thyroid cancer	0.00142	0.00233	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—thyroid cancer	0.00141	0.00232	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—thyroid cancer	0.00141	0.00231	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	0.0014	0.00752	CbGpPWpGaD
Prednisolone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00139	0.00747	CbGpPWpGaD
Prednisolone—Visual impairment—Epirubicin—thyroid cancer	0.00136	0.00223	CcSEcCtD
Prednisolone—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.00133	0.00716	CbGpPWpGaD
Prednisolone—Bradycardia—Doxorubicin—thyroid cancer	0.00133	0.00218	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00132	0.00712	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.00132	0.00709	CbGpPWpGaD
Prednisolone—Haemoglobin—Doxorubicin—thyroid cancer	0.00131	0.00215	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—thyroid cancer	0.0013	0.00214	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—thyroid cancer	0.00126	0.00207	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—thyroid cancer	0.00126	0.00206	CcSEcCtD
Prednisolone—Erythema—Epirubicin—thyroid cancer	0.00123	0.00201	CcSEcCtD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00122	0.00659	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00122	0.00655	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.0012	0.00647	CbGpPWpGaD
Prednisolone—Arrhythmia—Doxorubicin—thyroid cancer	0.00116	0.00191	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—thyroid cancer	0.00116	0.0019	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—thyroid cancer	0.00114	0.00187	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—thyroid cancer	0.00113	0.00186	CcSEcCtD
Prednisolone—Malaise—Epirubicin—thyroid cancer	0.00111	0.00182	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—thyroid cancer	0.0011	0.00181	CcSEcCtD
Prednisolone—Syncope—Epirubicin—thyroid cancer	0.0011	0.00181	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.0011	0.00591	CbGpPWpGaD
Prednisolone—Loss of consciousness—Epirubicin—thyroid cancer	0.00108	0.00177	CcSEcCtD
Prednisolone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.00107	0.00576	CbGpPWpGaD
Prednisolone—Vision blurred—Doxorubicin—thyroid cancer	0.00107	0.00176	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—thyroid cancer	0.00106	0.00175	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—THRB—thyroid cancer	0.00106	0.0057	CbGpPWpGaD
Prednisolone—Hypertension—Epirubicin—thyroid cancer	0.00106	0.00174	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00105	0.00173	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00104	0.00559	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00103	0.00556	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00103	0.00556	CbGpPWpGaD
Prednisolone—Discomfort—Epirubicin—thyroid cancer	0.00103	0.00169	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—thyroid cancer	0.00102	0.00168	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—thyroid cancer	0.00102	0.00167	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—thyroid cancer	0.00102	0.00167	CcSEcCtD
Prednisolone—Oedema—Epirubicin—thyroid cancer	0.001	0.00164	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—thyroid cancer	0.001	0.00164	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000997	0.00164	CcSEcCtD
Prednisolone—Shock—Epirubicin—thyroid cancer	0.000985	0.00162	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—thyroid cancer	0.000983	0.00161	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—thyroid cancer	0.00098	0.00161	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—thyroid cancer	0.000977	0.0016	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000968	0.00159	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000963	0.00518	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000961	0.00517	CbGpPWpGaD
Prednisolone—Discomfort—Doxorubicin—thyroid cancer	0.000955	0.00157	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000935	0.00503	CbGpPWpGaD
Prednisolone—Oedema—Doxorubicin—thyroid cancer	0.000926	0.00152	CcSEcCtD
Prednisolone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000926	0.00152	CcSEcCtD
Prednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000916	0.00493	CbGpPWpGaD
Prednisolone—Shock—Doxorubicin—thyroid cancer	0.000911	0.0015	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—thyroid cancer	0.000905	0.00149	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—thyroid cancer	0.000904	0.00148	CcSEcCtD
Prednisolone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000901	0.00485	CbGpPWpGaD
Prednisolone—Paraesthesia—Epirubicin—thyroid cancer	0.000899	0.00148	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000895	0.00147	CcSEcCtD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000894	0.00481	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—SLC5A5—thyroid cancer	0.000883	0.00475	CbGpPWpGaD
Prednisolone—Pain—Epirubicin—thyroid cancer	0.000856	0.00141	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—thyroid cancer	0.000838	0.00138	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—thyroid cancer	0.000832	0.00137	CcSEcCtD
Prednisolone—Feeling abnormal—Epirubicin—thyroid cancer	0.000825	0.00135	CcSEcCtD
Prednisolone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000808	0.00434	CbGpPWpGaD
Prednisolone—Urticaria—Epirubicin—thyroid cancer	0.000795	0.00131	CcSEcCtD
Prednisolone—Pain—Doxorubicin—thyroid cancer	0.000792	0.0013	CcSEcCtD
Prednisolone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.000775	0.00417	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000773	0.00416	CbGpPWpGaD
Prednisolone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000763	0.00125	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	0.000742	0.00399	CbGpPWpGaD
Prednisolone—Hypersensitivity—Epirubicin—thyroid cancer	0.000737	0.00121	CcSEcCtD
Prednisolone—Urticaria—Doxorubicin—thyroid cancer	0.000736	0.00121	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	0.00072	0.00387	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—TPR—thyroid cancer	0.000716	0.00385	CbGpPWpGaD
Prednisolone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000682	0.00112	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—MEN1—thyroid cancer	0.000673	0.00362	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000669	0.0036	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.000664	0.00357	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000664	0.00357	CbGpPWpGaD
Prednisolone—Dizziness—Epirubicin—thyroid cancer	0.000662	0.00109	CcSEcCtD
Prednisolone—CYP2A6—Biological oxidations—RXRA—thyroid cancer	0.00065	0.0035	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000647	0.00348	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	0.000641	0.00345	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000641	0.00345	CbGpPWpGaD
Prednisolone—Rash—Epirubicin—thyroid cancer	0.000631	0.00104	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—thyroid cancer	0.000631	0.00104	CcSEcCtD
Prednisolone—Headache—Epirubicin—thyroid cancer	0.000627	0.00103	CcSEcCtD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000618	0.00333	CbGpPWpGaD
Prednisolone—Dizziness—Doxorubicin—thyroid cancer	0.000612	0.00101	CcSEcCtD
Prednisolone—Nausea—Epirubicin—thyroid cancer	0.000595	0.000977	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	0.00059	0.00318	CbGpPWpGaD
Prednisolone—Rash—Doxorubicin—thyroid cancer	0.000584	0.000959	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—thyroid cancer	0.000583	0.000958	CcSEcCtD
Prednisolone—Headache—Doxorubicin—thyroid cancer	0.00058	0.000953	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000578	0.00311	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000569	0.00306	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000565	0.00304	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000554	0.00298	CbGpPWpGaD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000551	0.00296	CbGpPWpGaD
Prednisolone—Nausea—Doxorubicin—thyroid cancer	0.00055	0.000904	CcSEcCtD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000535	0.00288	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.000531	0.00286	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000525	0.00282	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000525	0.00282	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000516	0.00278	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000516	0.00277	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000492	0.00265	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—MINPP1—thyroid cancer	0.000478	0.00257	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—RXRA—thyroid cancer	0.00045	0.00242	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000449	0.00241	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000437	0.00235	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—HPGD—thyroid cancer	0.000428	0.0023	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NDUFA13—thyroid cancer	0.000406	0.00219	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000393	0.00211	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000385	0.00207	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CHST14—thyroid cancer	0.000382	0.00205	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—THRB—thyroid cancer	0.000373	0.00201	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000356	0.00191	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000347	0.00187	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00033	0.00178	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000329	0.00177	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000329	0.00177	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000325	0.00175	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—HPGD—thyroid cancer	0.000308	0.00166	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000284	0.00153	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PPARG—thyroid cancer	0.000284	0.00153	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—TPR—thyroid cancer	0.000252	0.00136	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TPR—thyroid cancer	0.000246	0.00132	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	0.000242	0.0013	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000242	0.0013	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000238	0.00128	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000237	0.00127	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CHST14—thyroid cancer	0.000227	0.00122	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000225	0.00121	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000225	0.00121	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000221	0.00119	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000219	0.00118	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000208	0.00112	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000208	0.00112	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	0.000184	0.00099	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—HPGD—thyroid cancer	0.000183	0.000986	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TPR—thyroid cancer	0.000177	0.000951	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000177	0.000951	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000175	0.000942	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	0.000174	0.000936	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000172	0.000928	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000168	0.000905	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00016	0.000859	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—RXRA—thyroid cancer	0.000158	0.000852	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—RXRA—thyroid cancer	0.000155	0.000832	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000154	0.000829	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.00015	0.000809	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000149	0.000801	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000141	0.00076	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CHST14—thyroid cancer	0.00014	0.000753	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC5A5—thyroid cancer	0.000132	0.000712	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000118	0.000637	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—HPGD—thyroid cancer	0.000113	0.000607	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—AKT1—thyroid cancer	0.000112	0.000604	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—RXRA—thyroid cancer	0.000111	0.000598	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TPR—thyroid cancer	0.000105	0.000566	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000105	0.000566	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	0.000104	0.000557	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PPARG—thyroid cancer	0.0001	0.000538	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PPARG—thyroid cancer	9.76e-05	0.000525	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.89e-05	0.000478	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC5A5—thyroid cancer	7.88e-05	0.000424	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS2—thyroid cancer	7.68e-05	0.000413	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PPARG—thyroid cancer	7.02e-05	0.000378	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTEN—thyroid cancer	6.7e-05	0.00036	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—RXRA—thyroid cancer	6.62e-05	0.000356	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TPR—thyroid cancer	6.48e-05	0.000349	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	6.38e-05	0.000343	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS2—thyroid cancer	5.52e-05	0.000297	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	4.85e-05	0.000261	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTEN—thyroid cancer	4.82e-05	0.000259	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PPARG—thyroid cancer	4.18e-05	0.000225	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—RXRA—thyroid cancer	4.08e-05	0.000219	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—AKT1—thyroid cancer	3.96e-05	0.000213	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKT1—thyroid cancer	3.86e-05	0.000208	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS2—thyroid cancer	3.29e-05	0.000177	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTEN—thyroid cancer	2.87e-05	0.000154	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKT1—thyroid cancer	2.78e-05	0.000149	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PPARG—thyroid cancer	2.57e-05	0.000138	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.03e-05	0.000109	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTEN—thyroid cancer	1.77e-05	9.5e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKT1—thyroid cancer	1.65e-05	8.89e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.02e-05	5.48e-05	CbGpPWpGaD
